Enzon Pharmaceuticals, Inc. (ENZN)

OTCMKTS: ENZN · Delayed Price · USD
0.300
0.000 (0.00%)
May 18, 2022 12:21 PM - Market open
Market Cap22.24M
Revenue (ttm)320,000
Net Income (ttm)-771,000
Shares Out74.21M
EPS (ttm)-0.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2
Open0.300
Previous Close0.300
Day's Range0.300 - 0.300
52-Week Range0.250 - 0.760
Beta-0.02
Analystsn/a
Price Targetn/a
Earnings Daten/a

About ENZN

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

IndustryBiotechnology
IPO DateFeb 15, 1984
CEOAndrew Rackear
CountryUnited States
Stock ExchangeOTCMKTS
Ticker SymbolENZN
Full Company Profile

Financial Performance

In 2021, ENZN's revenue was $701,000, an increase of 1,248.08% compared to the previous year's $52,000. Losses were -$469,000, -64.23% less than in 2020.

Financial Statements

News

Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon's CFO, to Assume Position of CE...

CRANFORD, N.J., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTC:ENZN) announced today that Andrew Rackear has communicated to the Board his intent to retire from his role as the Compa...

1 year ago - GlobeNewsWire

Enzon Pharmaceuticals Announces Results of Rights Offering

Looking to Next Step – Acquisition Opportunities Looking to Next Step – Acquisition Opportunities

1 year ago - GlobeNewsWire

Enzon Pharmaceuticals Announces Key Dates for Rights Offering

CRANFORD, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) announced today the record date and expected subscription period for its previously...

1 year ago - GlobeNewsWire

Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting

CRANFORD, N.J., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) today announced that its 2020 annual meeting of stockholders (the “Annual Meeting”)...

1 year ago - GlobeNewsWire

Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders

CRANFORD, N.J., Aug. 21, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC: ENZN) today announced that its Board of Directors (the “Board”) has approved a rights off...

1 year ago - GlobeNewsWire

Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder Value

CRANFORD, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (the “Company” or “Enzon”) (OTC:ENZN) today announced that its Board of Directors (the “Board”) adopted a tax benefits pre...

1 year ago - GlobeNewsWire